Korean J Fam Pract 2019; 9(1): 96-101  https://doi.org/10.21215/kjfp.2019.9.1.96
Relationship of Forced Vital Capacity with Chronic Kidney Disease among Middle-Aged and Elder Korean Men
Sol-Li Han, Byoungjin Park*
Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea
Byoungjin Park, Tel: +82-31-331-8710, Fax: +82-31-331-5551, E-mail: bjpark96@yuhs.ac, ORCID: http://orcid.org/0000-0003-1733-5301
Received: July 6, 2018; Revised: December 3, 2018; Accepted: December 26, 2018; Published online: February 20, 2019.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: It is unclear whether impaired pulmonary function serves as a risk factor for decreased renal function. This study investigated the association between the forced vital capacity (FVC) and chronic kidney disease (CKD) in middle-aged and elderly men.
Methods: We investigated the association between FVC and CKD in 412 Korean men aged ≥50 years, without diabetes, who have not received treatment for chronic lung disease. CKD was defined based on evidence of renal tissue damage or reduced renal function indicated by estimated glomerular filtration rate <60 mL/min/1.73 m2 or proteinuria level ≥1+. We assessed the association between FVC and CKD using multivariate logistic regression analysis after adjusting for confounders.
Results: The overall prevalence of CKD was 29.2% in the study population. Multivariate logistic regression analysis showed that the odds ratio with a 95% confidence interval for CKD was 0.96 (0.92–0.99) with a 1% increment in FVC after adjusting for age, body mass index, smoking status, alcohol intake, regular exercise, systolic and diastolic blood pressures, fasting plasma glucose, triglyceride, and high-density lipoprotein-cholesterol levels, as well as antihypertensive and antidyslipidemic medications.
Conclusion: We observed that FVC was independently and inversely associated with CKD. This finding suggests that careful monitoring of renal function is necessary to evaluate possible kidney dysfunction in patients with decreased FVC.
Keywords: Forced Vital Capacity; Pulmonary Function Test; Chronic Kidney Diseases
References
  1. Yoo KB, Choi JW, Kim BS, Kim TH. Socioeconomic burden of chronic kidney disease in South Korea. Korean Public Health Res 2014; 40: 13-23.
  2. Kim S, Lim CS, Han DC, Kim GS, Chin HJ, Kim SJ, et al. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci 2009; 24 Suppl: S11-21.
    Pubmed KoreaMed CrossRef
  3. Jin DC. Current status of dialysis therapy in Korea. Korean J Intern Med 2011; 26: 123-31.
    Pubmed KoreaMed CrossRef
  4. Luyckx VA, Tuttle KR, Garcia-Garcia G, Gharbi MB, Heerspink HJL, Johnson DW, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl 2017; 7: 71-87.
    Pubmed KoreaMed CrossRef
  5. Lee JY, Hwang YI, Park YB, Park JY, Kim KU, Oh YM, et al. Prevalence of spirometricallydefined restrictive ventilatory defect in Korea: the fourth-2, 3, and fifth Korean National Health and Nutrition Examination Survey, 20082012. J Korean Med Sci 2015; 30: 725-32.
    Pubmed KoreaMed CrossRef
  6. Hwang YI, Park YB, Yoo KH. Recent trends in the prevalence of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis (Seoul) 2017; 80:226-9.
    Pubmed KoreaMed CrossRef
  7. Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB. Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010. Chest 2013;143: 1395-406.
    Pubmed KoreaMed CrossRef
  8. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313: 7115; discussion 715-6.
    CrossRef
  9. Peers C, Dallas ML, Boycott HE, Scragg JL, Pearson HA, Boyle JP. Hypoxia and neurodegeneration. Ann N Y Acad Sci 2009; 1177: 169-77.
    Pubmed CrossRef
  10. Chen CY, Liao KM. Chronic obstructive pulmonary disease is associated with risk of chronic kidney disease: a nationwide case-cohort study. Sci Rep 2016; 6: 25855.
    Pubmed KoreaMed CrossRef
  11. Ji E, Kim YS. Prevalence of chronic kidney disease defined by using CKDEPI equation and albumin-to-creatinine ratio in the Korean adult population. Korean J Intern Med 2016; 31: 1120-30.
    Pubmed KoreaMed CrossRef
  12. Iseki K. Gender differences in chronic kidney disease. Kidney Int 2008; 74:415-7.
    Pubmed CrossRef
  13. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100.
    Pubmed CrossRef
  14. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest 2010; 137: 138-45.
    Pubmed KoreaMed CrossRef
  15. Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am Rev Respir Dis 1971; 103: 57-67.
    CrossRef
  16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63.
    CrossRef
  17. Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet 2014; 384:618-25.
    CrossRef
  18. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and restrictive lung function measures and CKD:National Health and Nutrition Examination Survey (NHANES) 20072012. Am J Kidney Dis 2016; 68: 414-21.
    Pubmed KoreaMed CrossRef
  19. Navaneethan SD, Schold JD, Jolly SE, Arrigain S, Winkelmayer WC, Nally JV Jr. Diabetes control and the risks of ESRD and mortality in patients With CKD. Am J Kidney Dis 2017; 70: 191-8.
    Pubmed KoreaMed CrossRef
  20. Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, et al. Effects of intensive BP control in CKD. J Am Soc Nephrol 2017; 28:2812-23.
    Pubmed KoreaMed CrossRef
  21. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137: 831-7.
    Pubmed CrossRef
  22. Yoon JH, Won JU, Ahn YS, Roh J. Poor lung function has inverse relationship with microalbuminuria, an early surrogate marker of kidney damage and atherosclerosis: the 5th Korea National Health and Nutrition Examination Survey. PLoS One 2014; 9: e94125.
    Pubmed KoreaMed CrossRef
  23. Heyman SN, Khamaisi M, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 2008; 28: 998-1006.
    Pubmed CrossRef
  24. Taddei S, Virdis A, Ghiadoni L, Sudano I, Notari M, Salvetti A. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension. Circulation 1999; 100: 1680-3.
    Pubmed CrossRef
  25. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806-16.
    Pubmed CrossRef
  26. Yoshizawa T, Okada K, Furuichi S, Ishiguro T, Yoshizawa A, Akahoshi T, et al. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels. Int J Chron Obstruct Pulmon Dis 2015; 10: 1283-9.
    Pubmed KoreaMed CrossRef
  27. Casanova C, de Torres JP, Navarro J, Aguirre-Jaíme A, Toledo P, Cordoba E, et al. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 182: 1004-10.
    Pubmed CrossRef
  28. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelialto-mesenchymal transition. J Clin Invest 2007; 117: 3810-20.
    Pubmed KoreaMed
  29. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008; 31: 1357-67.
    Pubmed CrossRef
  30. Hadeli KO, Siegel EM, Sherrill DL, Beck KC, Enright PL. Predictors of oxygen desaturation during submaximal exercise in 8,000 patients. Chest 2001;120: 88-92.
    Pubmed CrossRef


This Article


Author ORCID Information

Services
Social Network Service

e-submission

Archives